Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs

Expert Opinion on Therapeutic Targets
Charles J Malemud, Andrew H Miller

Abstract

Adult rheumatoid arthritis (RA) patients are frequently clinically depressed. Peripheral inflammation in RA may influence neurotransmitter metabolism, neuroendocrine function, synaptic plasticity, as well as growth factor production, which can modify neural circuitry and contribute to depression. A convergence between pro-inflammatory cytokine-induced synovial joint inflammation in RA and the effects of pro-inflammatory cytokines on the brain may occur through activation of the stress-activated/mitogen-activated protein kinases (SAPK/MAPK) and/or Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathways. The PubMed and Medlines databases were critically evaluated for evidence of SAPK/MAPK and/or JAK/STAT pathway activation in RA and depression. Some novel anti-depression drugs that were employed in animal models of 'sickness behavior' and in human depression clinical trials suppressed clinical markers of inflammation, as well as SAPK/MAPK and/or JAK/STAT signaling in vitro. Modifying pro-inflammatory cytokine signaling pathways in the brain with antidepressants may also be useful in ameliorating peripheral inflammation in RA.

References

Aug 1, 1996·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·G E WrightJ E Hewett
Mar 26, 1997·European Journal of Pharmacology·R S MansbachY L Chen
Nov 20, 1998·Frontiers in Bioscience : a Journal and Virtual Library·T K SchlesingerG L Johnson
Mar 10, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R Starr, D J Hilton
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M ZiolkowskaW Maslinski
Nov 30, 2000·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·K L SmarrG R Komatireddy
Mar 10, 2001·Nature·L Chang, M Karin
Oct 18, 2001·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·P IgazA Falus
Feb 16, 2002·Brain, Behavior, and Immunity·Michael Irwin
Aug 1, 2002·Journal of Clinical Immunology·Sudhir Gupta
Sep 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Akio MorinobuJohn J O'Shea
Oct 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ryuta NishikomoriWarren Strober
Mar 18, 2003·The Journal of Clinical Investigation·Paul J EganIan P Wicks
May 2, 2003·Psychosomatics·Chris DickensFrancis Creed
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Guy GriebelRégis Steinberg
Sep 18, 2003·Arthritis and Rheumatism·Monisha SundarrajanGary S Firestein
Mar 3, 2004·Molecular Interventions·Zigang Dong, Ann M Bode
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ismé M de KleerBerent Prakken
Jun 11, 2004·Nature·Tao LuBruce A Yankner
Jul 24, 2004·Biological Psychiatry·Ronald S Duman
Aug 21, 2004·Methods and Findings in Experimental and Clinical Pharmacology·S AppenzellerL T L Costallat
Aug 24, 2004·European Journal of Pharmacology·David H Overstreet, Guy Griebel
Oct 21, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sylvie Ferrari-LacrazThomas Moll
Nov 13, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiaohong WangAndrew H Miller
Nov 18, 2004·Immunological Reviews·Wendy T WatfordJohn J O'Shea
Dec 4, 2004·Biological Psychiatry·Lucile Capuron, Andrew H Miller
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Olga J G SchiepersMichael Maes
Jun 7, 2005·Journal of Neurochemistry·Tim D WerryArthur Christopoulos
Jun 9, 2005·The Journal of Experimental Medicine·Claudia R RuprechtFederica Sallusto
Jul 26, 2005·Pharmacology, Biochemistry, and Behavior·Agnieszka PałuchaAndrzej Pilc

❮ Previous
Next ❯

Citations

Nov 26, 2010·Journal of Neurology·Ming-Ou Lu, Jie Zhu
Sep 4, 2012·Archives of Pharmacal Research·Weon-Jong YoonEun-Sook Yoo
Nov 28, 2008·Nature Clinical Practice. Rheumatology·Jakko van IngenDick van Soolingen
Jan 29, 2010·Drugs & Aging·Charles J Malemud
Nov 19, 2014·Clinical Proteomics·Apeksha SahuSusarla Krishna Shankar
Mar 31, 2011·Expert Opinion on Therapeutic Targets·Feng-Lai YuanJian Dong
Feb 17, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·W J YoonC G Hyun
Dec 1, 2009·Neurobiology of Disease·Jennifer M LoftisBenjamin J Morasco
Mar 31, 2009·Brain Research Reviews·Irina N Krasnova, Jean Lud Cadet
Feb 17, 2009·Seminars in Arthritis and Rheumatism·Don L Goldenberg
Oct 31, 2012·Journal of Neurochemistry·Arabinda DasNaren L Banik
Apr 11, 2009·Neuroscience·J B Savitz, W C Drevets
Jan 17, 2017·Expert Review of Pharmacoeconomics & Outcomes Research·Usha SambamoorthiXiaohui Zhao
Jun 15, 2018·Reviews in the Neurosciences·Aisha S ShariqRoger S McIntyre
Apr 23, 2016·The European Respiratory Journal·Li LiLisa A Maier
Jul 14, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alexey P SarapultsevLarisa P Sidorova
Jul 25, 2009·Molecular and Cellular Biochemistry·Yukiko KondoEiichi Taira
Dec 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tahani K Alshammari
Jan 6, 2021·Annals of General Psychiatry·Maria Sole ChimentiRoberto Perricone
May 20, 2020·BMJ Open·Andres Reinoso-CoboAna Belen Ortega-Avila

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Cell Biology
H Birkedal-Hansen
Annals of the New York Academy of Sciences
D R RobinsonL Levine
Free Radical Biology & Medicine
D Jang, G A Murrell
© 2021 Meta ULC. All rights reserved